Jia Jie Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	309.94	112.94	354.42	125.53	172.28	344.16
Short-Term Investments	121.06	62.06	29.74	128.21	114.03	-
Trading Asset Securities	84.25	88.05	-	-	-	-
Cash & Short-Term Investments	515.25	263.05	384.17	253.75	286.31	344.16
Cash Growth	95.88%	-31.53%	51.40%	-11.37%	-16.81%	229.73%
Accounts Receivable	42.82	48.06	17.77	16.21	21.06	8.77
Other Receivables	3.08	1.85	2.82	2.78	3.38	8.2
Receivables	45.9	49.91	20.59	18.98	24.43	16.97
Inventory	21.29	24.49	24.68	26.64	20.8	15.05
Prepaid Expenses	8.12	7.98	4.99	17.23	8.65	3.48
Other Current Assets	3.07	2.91	2.89	0.61	0.1	0.07
Total Current Assets	593.62	348.34	437.31	317.21	340.28	379.73
Property, Plant & Equipment	448	450.75	448.81	451.21	444.91	453.55
Long-Term Investments	560.65	493.13	402.86	112.83	112.63	62.21
Goodwill	71.86	71.86	19.78	19.78	19.78	0.18
Other Intangible Assets	2.48	3.69	0.4	0.46	0.5	0.55
Long-Term Accounts Receivable	7.31	5.4	6.72	7.4	2.16	-
Long-Term Deferred Tax Assets	43.49	46.95	49.94	47.45	48.48	48.48
Other Long-Term Assets	112.12	62.18	47.11	47.62	52.66	44.72
Total Assets	1,840	1,482	1,413	1,004	1,021	989.42
Accounts Payable	13.62	12.46	11.27	10.3	11.72	10.16
Accrued Expenses	45.7	71.75	67.9	47.99	53.54	52.84
Short-Term Debt	-	-	237.45	-	-	-
Current Portion of Leases	2.53	2.46	0.81	2.53	2.29	2.25
Current Income Taxes Payable	7.51	5.28	1.57	0.38	0.91	0.38
Current Unearned Revenue	0.37	0.38	0.53	0.36	0.85	0.83
Other Current Liabilities	81.46	24.53	17.31	11.97	12.63	12.85
Total Current Liabilities	151.19	116.85	336.84	73.52	81.93	79.31
Long-Term Debt	5.12	4.03	4.7	5.18	1.51	-
Long-Term Leases	0.81	1.99	0.94	1.09	2.82	1.92
Other Long-Term Liabilities	2.17	0.21	0.21	0.21	0.21	0.21
Total Liabilities	159.28	123.08	342.69	80	86.47	81.44
Common Stock	1,187	987.37	889.37	889.37	889.37	889.37
Additional Paid-In Capital	251.05	91.05	58.3	57.01	57.01	87.62
Retained Earnings	313.39	349.83	163.02	18.87	24.28	-8.87
Comprehensive Income & Other	-100.67	-97.23	-63.82	-67.27	-62.79	-58.83
Total Common Equity	1,651	1,331	1,047	897.98	907.87	909.28
Minority Interest	29.11	28.19	23.35	25.99	27.05	-1.31
Shareholders' Equity	1,680	1,359	1,070	923.96	934.92	907.97
Total Liabilities & Equity	1,840	1,482	1,413	1,004	1,021	989.42
Total Debt	8.46	8.48	243.9	8.8	6.61	4.17
Net Cash (Debt)	506.8	254.57	140.26	244.95	279.69	339.99
Net Cash Growth	99.42%	81.49%	-42.74%	-12.42%	-17.73%	1652.35%
Net Cash Per Share	4.55	2.59	1.57	2.75	3.14	4.90
Filing Date Shares Outstanding	118.74	98.74	88.94	88.94	88.94	88.94
Total Common Shares Outstanding	118.74	98.74	88.94	88.94	88.94	88.94
Working Capital	442.44	231.49	100.47	243.7	258.36	300.42
Book Value Per Share	13.91	13.48	11.77	10.10	10.21	10.22
Tangible Book Value	1,577	1,255	1,027	877.74	887.59	908.56
Tangible Book Value Per Share	13.28	12.72	11.54	9.87	9.98	10.22
Land	178.91	178.91	178.91	178.55	171.76	171.76
Buildings	380.97	380.85	382.81	380.89	376.79	376.59
Machinery	98.96	92.92	78.21	92.18	86.21	88.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.